TORRENT PHARMACEUTICALS
Back to Income Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Operating Profit History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Operating Profit (Excl OI) | ₹2,431 Cr | ₹2,480 Cr | ₹2,170 Cr | ₹1,976 Cr | ₹1,341 Cr |
What is the latest Operating Profit of TORRENT PHARMACEUTICALS ?
Year | Operating Profit |
---|---|
Mar2023 | ₹2,431 Cr |
Mar2022 | ₹2,480 Cr |
Mar2021 | ₹2,170 Cr |
Mar2020 | ₹1,976 Cr |
Mar2019 | ₹1,341 Cr |
How is Operating Profit of TORRENT PHARMACEUTICALS Trending?
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹2,431 Cr | -1.97 | |
Mar2022 | ₹2,480 Cr | 14.27 | |
Mar2021 | ₹2,170 Cr | 9.81 | |
Mar2020 | ₹1,976 Cr | 47.38 | |
Mar2019 | ₹1,341 Cr | - |
Compare Operating Profit of peers of TORRENT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TORRENT PHARMACEUTICALS | ₹92,471.2 Cr | 1.6% | 2% | 61.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹361,916.0 Cr | 0.3% | -7.5% | 53.9% | Stock Analytics | |
CIPLA | ₹115,034.0 Cr | 1.1% | -4.8% | 56.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,929.0 Cr | 1.6% | 1.6% | 27.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,873.0 Cr | -1.9% | 10.7% | 21.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 5.2% | -0.2% | 90.1% | Stock Analytics |
TORRENT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TORRENT PHARMACEUTICALS | 1.6% |
2% |
61.8% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses